Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA-DR antibody

The Mouse Monoclonal anti-HLA-DR antibody has been validated for FACS, WB, IHC, IF, ISt and StM. It is suitable to detect HLA-DR in samples from Human.
Catalog No. ABIN6939641

Quick Overview for HLA-DR antibody (ABIN6939641)

Target

HLA-DR

Reactivity

  • 129
  • 20
  • 17
  • 16
  • 16
  • 13
  • 11
  • 8
  • 6
  • 4
  • 3
  • 3
  • 2
  • 1
Human

Host

  • 106
  • 15
  • 12
  • 1
Mouse

Clonality

  • 125
  • 6
  • 1
Monoclonal

Conjugate

  • 48
  • 15
  • 15
  • 8
  • 8
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLA-DR antibody is un-conjugated

Application

  • 115
  • 43
  • 29
  • 25
  • 14
  • 13
  • 12
  • 10
  • 10
  • 7
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunostaining (ISt), Staining Methods (StM)

Clone

SPM289
  • Specificity

    This MAb reacts with the beta-chain of HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. The L243 antibody recognizes a different epitope than the SPM289 monoclonal antibody, and these antibodies do not cross-block binding to each other's respective epitopes. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Purification

    Purified by Protein A/G

    Immunogen

    Activated human peripheral blood mononuclear cells

    Isotype

    IgG2b kappa
  • Application Notes

    Positive Control: Raji, Ramos, Daudi or HuT78 cells. Spleen, Tonsil or lymph node.

    Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (2-4 μg/mL), Western Blot (0.5-2 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    HLA-DR

    Alternative Name

    HLA-DR

    Molecular Weight

    ~28kDa (beta chain)

    Gene ID

    3123

    UniProt

    P01903

    Pathways

    Human Leukocyte Antigen (HLA) in Adaptive Immune Response
You are here:
Chat with us!